Healing
Vesugen
Longevity
3
Amino acids
Molecular weight
Peptide
Type
Vesugen is a Khavinson bioregulator tripeptide developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology. Composed of three amino acids (lysine, glutamic acid, aspartic acid), it targets the vascular system and protects blood vessels from age-related decline. Research shows it limits atherosclerosis development, decreases endothelial dysfunction, and activates stem cells. Like other short Khavinson peptides, Vesugen penetrates to the nucleus where it influences gene expression.
Vesugen works through epigenetic regulation by interacting with DNA promoter regions, particularly affecting Ki-67 gene expression which controls cell division. It plays a prominent role in regulating sirtuin 1 (SIRT1) protein levels - a key anti-aging protein activated during calorie restriction. Vesugen enhances mesenchymal stem cell proliferation, reduces senescence markers, improves cell differentiation, and may reverse the Senescence-Associated Secretory Phenotype (SASP) implicated in age-related cardiovascular disease.
Oral capsules: room temperature; Lyophilized powder/reconstituted: 2-8°C refrigerated
Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
10-20 mg per day (oral capsules) or 10 mg (injectable)
10-20 day cycle
Protects vascular system from aging effects
Limits atherosclerosis development
Decreases endothelial cell dysfunction
Activates SIRT1 anti-aging pathway
Enhances stem cell proliferation
Reduces cellular senescence markers
Reverses SASP phenotype
Works synergistically with Cardiogen
This peptide is still gaining traction in the community.
KED | Vascular Bioregulator Peptide
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of Vesugen.
3
Amino Acids
Vesugen
Lys
Lys
Position 1
Glu
Glu
Position 2
Asp
Asp
Position 3
Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles, often repeated 2-3 times per year.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10 | 10 week range | Oral capsules |
| Maintenance | 10 | 2 week range | Oral capsules |
The Vesugen Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
Vesugen
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Vesugen vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of Vesugen interactions with other common peptides and substances.
Healing
car
Longevity
SYNERGISTIC
Complementary cardiovascular bioregulators - Vesugen for vessels, Cardiogen for heart tissue.
Longevity
epi
Immunity
SYNERGISTIC
Often combined in comprehensive anti-aging Khavinson protocols.
Cognitive
pin
Longevity
COMPATIBLE
Part of Khavinson bioregulator family; targets different tissue.
Longevity
thy
Immunity
COMPATIBLE
Different organ targets; can be used in comprehensive bioregulator protocols.
Active cardiovascular emergencies (seek medical care)
Known hypersensitivity
Pregnancy or breastfeeding
Allergic reactions
Unusual cardiovascular symptoms
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Vesugen is a moderate research compound
Vesugen
Vesugen is a moderate research compound
Khavinson Peptide Bioregulators Research
Comprehensive review of bioregulator peptides including Vesugen and their epigenetic mechanisms.
n.d.
Short Peptides and Vascular Aging
Short peptides regulate sirtuin 1 levels and protect vascular tissue from aging.
n.d.
Mesenchymal Stem Cell Activation by Peptide Bioregulators
Vesugen enhances MSC proliferation and reduces senescence markers in stem cells.
n.d.